Brand Protection: In the face of mounting counterfeiting, diversion & other infringements. Jim Mentone Director, Consumer Global Brand Protection
|
|
- Corey Bennett
- 6 years ago
- Views:
Transcription
1 Brand Protection: In the face of mounting counterfeiting, diversion & other infringements Jim Mentone Director, Consumer Global Brand Protection
2 Objective: Create active collaboration group MFGs & Retailers: Help protect consumers & patients o Counterfeiting & diversion is serious and growing Support Branding & Consumer Confidence o Manufacture & Retailer Support Business Growth o Alignment with business strategies Confidential 2
3 What s a counterfeit? Fake product in a fake package? Fake product in a genuine package? The real product repackaged in a real or fake package? The real product repackaged to extend a shelf life? The real product from a different country repackaged? Yes! All / Any of the above Confidential 3
4 Counterfeiting Apparel, DVDs, watches... money, cigarettes... But. Healthcare??? Pharmaceuticals? Medical Devices? Consumer Products? Shampoo?, Soap?,... Really? Confidential 4
5 Counterfeiting is a large and growing business The World Health Organization (WHO) states that worldwide sales of counterfeit medicines could top $75 billion, a 90% increase in five years 30% of certain drugs consumed in developing countries are counterfeit In Africa estimates are that 50% of the anti-malarias and HIV drugs are counterfeit The Threat is Real... Confidential 5
6 Counterfeiting an issue primarily outside US... RIGHT? Estimates for US: 1% of pharmaceuticals are counterfeit 5% of Consumer products and Medical Devices imported into the United States are counterfeit Confidential 6
7 If you re a category leader, you re a target for counterfeiting In the last 5 years: We have identified counterfeit products in every major category We have identified counterfeit products in every region of the world We have identified counterfeits in every channel of sale Counterfeiting is a problem for consumer goods and the healthcare industry in general! Confidential 7
8 Confidential 8
9 Diversion Not Just a Business Issue Diversion may result in mishandling or contamination of products Diversion enables counterfeiters Diversion is how counterfeits are inserted into legitimate channels Confidential 9
10 Why Global Brand Protection (GBP)? Patient Safety Patient Safety Patient Safety Reputation of the product Reputation of the brand Reputation of the manufacturer & Retailer Legal liability Centralized Brand Protection function consists of Global Sector Leads for strategy and regional coverage Regional (cross-sector) Leads for emerging markets Central support for anticounterfeiting (ACF) technology and programs Confidential 10
11 Safe & Secure Supply Chain 1. Incident Reporting and Management 2. Awareness and Education 3. Market Monitoring 4. Commercial Insights 5. Distributor Compliance 6. External Manufacturer 7. Product Protection 8. Product Returns and Destruction 9. Transportation Security 10. Facility Security Confidential 11
12 Safe & Secure Supply Chain Practices 1. Incident Reporting and Management Prompt reporting and management is critical to protect our patients 2. Market Monitoring 3. Commercial Insights Monitoring can identify issues before a product is dispensed to patients Internally available commercial data can guide our monitoring efforts and help investigate incidents Confidential 12
13 Safe & Secure Supply Chain Practices 4. Awareness and Education 5. Distributor Compliance 6. External Manufacturer Awareness and Education can further our efforts by involving all associates and business partners Contractual language and proper due diligence can create a safer supply chain Implementation of measures to mitigate the inherent risks associated with using an external partner in a global supply chain Confidential 13
14 Safe & Secure Supply Chain Practices 7. Product Protection Risk-based assessments for new products Technology is applied based on level and type of risk Not serialization! 8. Product Returns and Destruction Eliminate possibility of counterfeit product being restocked and sold Reduce possibility that product meant for destruction ends up in the grey market Confidential 14
15 Safe & Secure Supply Chain Practices 9. Transportation Security Proper transportation security can reduce theft and pilferage, reducing source of product for grey market 10. Facility Security Facility security is vital for both finished goods and for WIP and packaging materials Confidential 15
16 Summary: Need to create active collaboration group: Protect consumers & patients o Counterfeiting & diversion is serious and growing Preserve Branding & Enhance Consumer Confidence o Manufacture & Retailer Support Business Growth o Alignment with business strategies Confidential 16
17 Thank You! For more information, please contact Jim Mentone (908) Confidential 17
Counterfeit Drugs and Supply Chain Security
Counterfeit Drugs and Supply Chain Security Rick Mitzner Senior Director, Engineering Technology Pfizer, Inc. Interphex April 21, 2015 Tragic Consequences Not If But When and Where May 7, 2007 80 children
More informationSUPPLY CHAIN SECURITY MAINTAINING INTEGRITY OF YOUR SUPPLY CHAIN
SUPPLY CHAIN SECURITY MAINTAINING INTEGRITY OF YOUR SUPPLY CHAIN WORKSHOP 28 August 2017 Tony Zook Why is this important? http://www.cbsnews.com/news/fda-warns-about-fake-avastin-again/ 2 Why is this important?
More informationCounterfeit Pharmaceuticals Supply Chain
Counterfeit Pharmaceuticals Supply Chain Session 168 February 13, 2019 Alanna Lavelle, Senior Principal, MITRE Corporation Cathy Begley, Executive Director, Merck 2019 The MITRE Corporation All Rights
More informationHow serialisation will change our supply chains? GS 1 Conference Addis Ababa May 9, 2018
How serialisation will change our supply chains? GS 1 Conference Addis Ababa May 9, 2018 Patient safety through Serialisation and Authentication Imperial Logistics move approximately 400 million patient-packs
More informationInternational and ANVISA Traceability Requirements
International and ANVISA Traceability Requirements 1 Buenos Aires ETIF 2010 - International and ANVISA Traceability Requirements G. Rossi 2010 rev. 1.0 1. Supply Chain Issues 2. COUNTERFEITING 3. Worldwide
More informationAnti-counterfeiting Watch Solutions
Anti-counterfeiting Watch Solutions PROBLEM: Pawnbrokers v. Counterfeit Watches Due to the nature of the pawnbroker s business, they are exposed to increasing numbers of counterfeit watches being targeted
More informationINTA Response to DG Enterprise & Industry s Public Consultation in Preparation of a Legal Proposal to Combat
INTA Response to DG Enterprise & Industry s Public Consultation in Preparation of a Legal Proposal to Combat Counterfeit Medicines for Human Use: Key Ideas for Better Protection of Patients against the
More informationWHITE PAPER. Solutions to Global Pharmaceutical Supply Chain Challenges
WHITE PAPER Solutions to Global Pharmaceutical Supply Chain Challenges Solutions to Global Pharmaceutical Supply Chain Challenges Find out how a contract packaging company can deliver the expertise and
More informationBrand protection and authentication
Issues and opportunities Mike Fairley Director, Strategic Development Labels and Packaging Group Tarsus Group Question: What do the following have in common? Robbie Williams Nike Viagra Microsoft software
More informationSECURING THE SUPPLY CHAIN WITH SERIAL NUMBERS
SECURING THE SUPPLY CHAIN WITH SERIAL NUMBERS How secure mass serialization can help fight counterfeiting, diversion and theft. Verify Brand 3033 Campus Drive, Minneapolis MN 55441 info@verifybrand.com
More informationAnti-counterfeiting Watch Solutions PROBLEM: Pawnbrokers v. Counterfeit Watches Due to the nature of the pawnbroker s business, they are exposed to increasing numbers of counterfeit watches being targeted
More informationCURE FOR THE COUNTERFEITING PANDEMIC IN THE AUTOMOTIVE INDUSTRY
RFID IOT NFC Confidex and Sasken proudly present the Dynamic Parts Authentication TM CURE FOR THE COUNTERFEITING PANDEMIC IN THE AUTOMOTIVE INDUSTRY JUNE 2017 INTRODUCTION Apparel, accessories, music,
More informationGood Manufacturing Practices. Single Points of Contact. Surveillance and Monitoring. Good Distribution Practices. Track and Trace System
Single Points of Contact Good Manufacturing Practices Surveillance and Monitoring Good Distribution Practices 10 1 9 Track and Trace System 2 8 3 7 Good Import/ Export Practices 4 6 5 Internet Sales Clinical
More informationSummary of Proposed USP General Chapter <1083> Good Distribution Practices Supply Chain Integrity 02/15/2012
Summary of Proposed USP General Chapter Good Distribution Practices Supply Chain Integrity 02/15/2012 This summary was prepared by the Rx-360 Monitoring and Reporting Working Group which tracks
More informationEffective Brand Protection & Supply Chain Integrity Strategies. Ron Guido President, LifeCare Services, LLC September 9, 2014
Effective Brand Protection & Supply Chain Integrity Strategies Ron Guido President, LifeCare Services, LLC September 9, 2014 Agenda Call to action to safeguard healthcare supply Supply chain vulnerabilities
More informationThe online counterfeit economy: consumer electronics
The online counterfeit economy: consumer electronics The digital world is filled with various ways for counterfeiters to attack your brand and turn a profit for themselves, all while under the cloak of
More informationProtecting Critical Care Drugs
Protecting Critical Care Drugs Securing the Most Susceptible Products from Counterfeiting The growth of injectable critical care therapeutics requires multi-layer protection and authentication solutions.
More informationGS1 Ireland Healthcare User Group (HUG) Information Day
GS1 Ireland Healthcare User Group (HUG) Information Day Overview on EU FMD regulation and unique identification requirements Geraldine Lissalde-Bonnet, GS1 Global Office 28 th March 2017 Overview on EU
More informationThe Danish Generic Medicines Industry Association (IGL)
The Danish Generic Medicines Industry Association (IGL) comments on the concept paper on the delegated act for a unique identifier for medicinal products for human use, and its verification. The Danish
More informationENCODING, PRINTING & VALIDATING RFID TAGS WITH PORTALTRACK
ENCODING, PRINTING & VALIDATING RFID TAGS WITH PORTALTRACK Maximizing Your RFID Investment with PortalTrack from MSM Solutions MSM Solutions PortalTrack gives you the freedom to tailor your RFID and Barcode
More informationAbout Us. What is the future of pharmacy business? Why Pharmacy business?
About Us Kingsmann Pharmacies is a UK based Pharmacy Chain specialising in healthcare and branding. We use economies of scale to help reduce costs allowing us to pass these on to group members. We provide
More informationTaking a Leap Toward Global Supply Chain Efficiency - Part II
Taking a Leap Toward Global Supply Chain Efficiency - Part II 2 Supply Chain Brochure - Part II INTRODUCTION Pharmaceutical manufacturers face a number of challenges in the production and delivery of medicinal
More informationSecuring Your Supply Chain How to Prevent Counterfeit Plastic Parts and Products
Securing Your Supply Chain How to Prevent Counterfeit Plastic Parts and Products While counterfeiting statistics are difficult to obtain because it is a clandestine industry, one thing everyone can agree
More informationSupply chain integrity Fighting counterfeiting in healthcare
Supply chain integrity Fighting counterfeiting in healthcare The increasing, global threat of counterfeiting in healthcare What is the problem? Counterfeit drugs may harm the patient. Often impossible
More informationTimeline for the Drug Supply Chain and Security Act
April 2014 Timeline for the Drug Supply Chain and Security Act (Title II, Drug Quality and Security Act, 2013) Overview The Drug Supply Chain and Security Act (Title II, Drug Quality and Security Act,
More informationCode of Practice for Holder of Certificate of Registration as an Importer and Exporter of Pharmaceutical Products
Code of Practice for Holder of Certificate of Registration as an Importer and Exporter of Pharmaceutical Products March 2014 Table of Content INTRODUCTION 3 Section 1: GENERAL RESPONSIBILITIES OF HOLDER
More informationTRACEABILITY: SOLVING CHALLENGES & ADDING VALUE IN ELECTRONICS MANUFACTURING
TRACEABILITY: SOLVING CHALLENGES & ADDING VALUE IN ELECTRONICS MANUFACTURING By Rob Prosser, global product manager, industrial ID materials, Brady Corporation Last updated: May 2014 TRACEABILITY: SOLVING
More informationImpact of Drug Supply Chain Security Act on US Pharmaceutical Industry Under Decentralized Information Flow. Meng Ying Chang, Raghavendran Mohan
Impact of Drug Supply Chain Security Act on US Pharmaceutical Industry Under Decentralized Information Flow Meng Ying Chang, Raghavendran Mohan Agenda Drug Supply Chain Security Act (DSCSA) Implementation
More informationSerialization and epedigree: New Opportunities for Life Sciences Manufacturers
Serialization and epedigree: New Opportunities for Life Sciences Manufacturers Table of Contents Serialization and epedigree: Current Direction... 3 Why Invest in Serialization?... 3 What Tasks do Life
More informationEurope Fights Back against Counterfeit Medication with the European Falsified Medicines Directive (2011/62/CE)
Europe Fights Back against Counterfeit Medication with the European Falsified Medicines Directive (2011/62/CE) The instances of falsified medicines in Europe are increasing at a dramatic rate. Medication
More informationA-CAPP Paper Series. Assessing the Risks of Counterfeiting and Illicit Diversion for Health Care Products
A-CAPP Paper Series Assessing the Risks of Counterfeiting and Illicit Diversion for Health Care Products Christopher Trent Senior Manager, Product Protection Johnson & Johnson Global Brand Protection November
More informationOverview of the IMPACT Working Group on Legislative and Regulatory Infrastructure
Overview of the IMPACT Working Group on Legislative and Regulatory Infrastructure Medical products are essential to cure diseases and to safe lives. If a medical product cannot achieve this goal because
More informationOverview of the IMPACT Working Group on Legislative and Regulatory Infrastructure
Overview of the IMPACT Working Group on Legislative and Regulatory Infrastructure Medical products are essential to cure diseases and to safe lives. If a medical product cannot achieve this goal because
More informationPROTECTING BRANDS FROM PRODUCT COUNTERFEITING
PROTECTING BRANDS FROM PRODUCT COUNTERFEITING EXECUTIVE SUMMARY The manufacture and sale of counterfeit goods is a global problem that directly impacts legitimate producers and retailers in every industry.
More informationPharmaceutical RFID: From Mandates to Endorsements and Laws
Pharmaceutical RFID: From Mandates to Endorsements and Laws By Sara Shah, Industry Analyst, RFID and M2M Research, ABI Research The healthcare industry s motivation for adopting RFID can be attributed
More informationHealthcare Sector. - Upcoming legislations - GS1 standards. Ann Luyckx Healthcare Manager. Phi Data Event 2018
Healthcare Sector - Upcoming legislations - GS1 standards Ann Luyckx Healthcare Manager Phi Data Event 2018 Anti-trust GS1 Belgium & Luxembourg will not enter into any discussion, activity or conduct that
More informationSE09. Track & Trace Solutions Jeff Bredemus Werner Electric
SE09 Track & Trace Solutions Jeff Bredemus Werner Electric Related Topics SE02 Balluff RFID SE03 Benefits of Image Based Barcode Reading SE08 Vision Solutions for the Food Ind. Solution Area 5 (Motion
More informationVerification of Pharmaceutical Products at the Point of Dispense. An EFPIA update
Verification of Pharmaceutical Products at the Point of Dispense Speaker : Grant Courtney Event: GS1 Global Conference Location: Washington An EFPIA update 1 Who is EFPIA? The European Federation of Pharmaceutical
More informationSTRATEGIES FOR DRUG ANTI-COUNTERFEITING IN GLOBAL SUPPLY CHAIN
STRATEGIES FOR DRUG ANTI-COUNTERFEITING IN GLOBAL SUPPLY CHAIN 1 EXECUTIVE SUMMARY Emerging markets are expected to contribute a major share of the growth percentage in global pharma business. Plans have
More informationUnited States House Energy and Commerce Committee. Subcommittee on Health. Hearing on Securing Our Nation s Prescription Drug Supply Chain
United States House Energy and Commerce Committee Subcommittee on Health Hearing on Securing Our Nation s Prescription Drug Supply Chain Testimony of Timothy Davis, Independent Pharmacist and Member of
More informationMass Serialization and Traceability Implementation in the Pharma Industry. Mathieu Aman, Global Program Lead F. Hoffmann-La Roche Ltd, Switzerland
Mass Serialization and Traceability Implementation in the Pharma Industry Mathieu Aman, Global Program Lead F. Hoffmann-La Roche Ltd, Switzerland What drives the industry towards more traceability Strategic
More informationPatients are Counting on Us: It s Time to Act
Patients are Counting on Us: It s Time to Act Brian Johnson Chairman Rx-360 Senior Director Supply Chain Security Pfizer, Inc. 24 th Global GS1 Healthcare Conference October 2, 2013 THE WALL STREET JOURNAL
More informationGet to Market Faster and Avoid Costly Mistakes: New FDA Guidance for RF Wireless Medical Devices
Get to Market Faster and Avoid Costly Mistakes: New FDA Guidance for RF Wireless Medical Devices To help companies ensure the proper functioning of wireless medical devices, the FDA recently released final
More informationCharter on Access to Health in Developing Countries
Charter on Access to Health in Developing Countries Fake Medicines July 2014 Our Promise Merck is a leading company for innovative and top-quality high-tech products. As the oldest pharmaceutical and chemical
More informationCapabilities Overview Presentation. Presenter
Capabilities Overview Presentation Presenter About Baxter Global, diversified healthcare company 80 years of parenteral expertise driven by a well recognized global brand $12.6 billion global market leader
More informationRegulatory Update: The US Drug Supply Chain Security Act (DSCSA) December 2017
Regulatory Update: The US Drug Supply Chain Security Act (DSCSA) December 2017 Regulatory Agency Regulation Name or System Name Compliance Dates U.S. Department of Health and Human Services (HHS), Food
More informationDrug Safety and FDA Revitalization Legislation
Drug Safety and FDA Revitalization Legislation Dan Kracov August 23, 2007 FDA Regulatory and Compliance Symposium House and Senate FDA Revitalization Bills Senate: S. 1082, Food and Drug Administration
More informationHealth Products and Food Branch Inspectorate
Our Mandate: To promote good nutrition and informed use of drugs, food, medical devices and natural health products, and to maximize the safety and efficacy of drugs, food, natural health products, medical
More informationUSE OF MOBILE TECHNOLOGY RELATED TO PRODUCT QUALITY MONITORING
USE OF MOBILE TECHNOLOGY RELATED TO PRODUCT QUALITY MONITORING Paul B. Orhii MD, JD, PhD. (Director General NAFDAC Nigeria) WHAT IS A COUNTERFEIT/FAKE MEDICINE?: "А counterfeit medicine is one which is
More informationAgenda. The Past: 1990 s. Healthcare. Supply Efficiencies Pallet Through Retail Packages The Present:
Agenda The Past: 1990 s Supply Efficiencies Pallet Through Retail Packages The Present: 2000-2005 Prevention of Dispensing Errors Unit Dose and Unit of Use Packages The Future: 2005 Forward Counterfeit
More informationGetting serious about serialization: A comprehensive look at the legislation shaping U.S. pharmaceutical supply chains
Getting serious about serialization: A comprehensive look at the legislation shaping U.S. pharmaceutical supply chains ------------------------------------------------------------------------------------------------------------
More informationVol. 2 Management RFP No. QTA0015THA A2-2
Manufacturing and Assembly: All MetTel manufacturing and assembly activities are focused on the reduction of supply chain risk. MetTel s SCRM Plan and the associated Systems Acquisition (SA) controls for
More informationGlobal Track & Trace requirements for better and safer Healthcare
Global Track & Trace requirements for better and safer Healthcare Ulrike Kreysa, VP Healthcare, GS1 Global Office Riyadh, 6 th December 2016 Counterfeiting - The Impact According to Interpol more than
More informationNissan Putting the Brakes on Counterfeit Parts
CASE STUDY Nissan Putting the Brakes on Counterfeit Parts Industry: Consumer Goods Company: Headquarters: Products: Nissan North America Inc. Franklin, TN MarkMonitor Brand Protection OVERVIEW Nissan North
More informationThe world of GS1 standards in healthcare. Chris Adcock GS1 Global Office
The world of GS1 standards in healthcare Chris Adcock GS1 Global Office Topics Background Where we are going Where we are today What this means to you Questions Background Topics Where we are going Where
More informationGS1 Standards are Vital for Pharma Serialisation
GS1 Standards are Vital for Pharma Serialisation Michele Francis Padayachee 23 November 2018 GS1 2015 Antitrust Caution Participants on GS1 committees, task forces, work groups, task groups, or other similar
More informationBRAND PROTECTION STRATEGIES: Defending Against Gray Market Diversion
BRAND PROTECTION STRATEGIES: Defending Against Gray Market Diversion EXECUTIVE WHITE PAPER Solutions for Business Consulting. Technology. Results. Executive Summary In this rapidly changing global economy,
More informationECIA Distributor Counterfeit Product Mitigation Internal Audit Checklist
ECIA Publication ECIA Distributor Counterfeit Product Mitigation Internal Audit Checklist Based on SAE s AS6496 - Fraudulent/Counterfeit Electronic Parts: Avoidance, Detection, Mitigation, and Disposition
More informationMarkMonitor Pharmaceutical Industry Solution
SOLUTION BRIEF It costs millions and takes years to build a successful pharmaceutical brand only to have it undermined by unauthorized online channels and targeted attacks. MarkMonitor Pharmaceutical Industry
More informationSerialization Primer
Serialization Primer Introduction Global pharmaceutical distribution networks and supply chains have become more complex and interconnected, quickening the pace of regulations that mandate pharmaceutical
More informationSupplier Oversight PQRI. September Steven Lynn, MS, CMQ/OE Vice President Global Quality Compliance Mylan
Supplier Oversight September 2014 PQRI Steven Lynn, MS, CMQ/OE Vice President Global Quality Compliance Mylan Agenda Mylan Background Setting the Stage with a Scenario Current State Thinking Supplier Qualification
More informationBusiness integrity and sustainable growth: making the intelligent connection Fraud Investigation & Dispute Services
Business Integrity and Corporate Compliance Business integrity and sustainable growth: making the intelligent connection Fraud Investigation & Dispute Services We make the connection between integrity,
More informationApplication for registration certificate to operate a retail pharmacy 5, ,000.00
Appendix 3: Pharmaceutical Regulatory Authority Schedule of Fees, 2010 A. RETAIL / HOSPITAL PHARMACY FEE UNITS (1 fee Unit = K180) APPLICATION FEES (ZMK) 1 2 Application for registration certificate to
More information1201 Maryland Avenue SW, Suite 900, Washington, DC ,
1201 Maryland Avenue SW, Suite 900, Washington, DC 20024 202-962-9200, www.bio.org April 16, 2009 Dockets Management Branch (HFA-305) Food and Drug Administration 5600 Fishers Lane, Rm. 1061 Rockville,
More informationBSWH Technician Continuing Education 2016 Part 2: Pharmacy Law - Controlled Substance Security & Drug Supply Chain Security Act (DSCSA) Contact
BSWH Technician Continuing Education 2016 Part 2: Pharmacy Law - Controlled Substance Security & Drug Supply Chain Security Act (DSCSA) Contact Hours: 1.5 Objectives List some strategies regarding safe
More information<1079> Good Storage and Distribution Practices
Good Storage and Distribution Practices Desmond Hunt, Ph.D. Principal Scientific Liaison September 7, 2017 Mexico City, Mexico Good Distribution Practice Activities Suppliers Procuring, holding,
More informationApplying Academic Research Against Product Counterfeiting
January 2016 Since its launch as the first academic body focusing on the complexities of anti-counterfeiting and product protection, the Center for Anti-Counterfeiting and Product Protection at Michigan
More informationDrug Supply Chain Security Act Implementation Track and Trace Issues in 2017
Drug Supply Chain Security Act Implementation Track and Trace Issues in 2017 ILISA BG BERNSTEIN, PharmD, JD Deputy Director, Office of Compliance FDA/CDER Presented at: FDLI DQSA Conference November 15,
More informationForensic services Protecting your business from fraud, misconduct and non-compliance Risk Consulting
Forensic Protecting your business from fraud, misconduct and non-compliance Risk Consulting KPMG.com/in KPMG in India s Forensic Protect Anti-bribery and corruption compliance Anti-money laundering Fraud
More informationThe U.S. Wholesaler Market: Past, Present and Future
The U.S. Wholesaler Market: Past, Present and Future 2012 H. D. Smith National Sales & Management Conference August 8, 2012 John M. Gray President and CEO HDMA The History of HDMA 1876 2012 Exchange Hall,
More informationTrademarks & Brand Protection for Pharma and Medical Devices
Trademarks & Brand Protection for Pharma and Medical Devices Monica Riva Talley September 15, 2017 Agenda 1. Why Trademarks are Critical in Pharma 2. Pharma Trademarks are Different Clearance Considerations
More informationRAIN, Cloud & the Chained Twin. Chris Diorio CEO, Impinj
RAIN, Cloud & the Chained Twin Chris Diorio CEO, Impinj Suppose You Wanted to Connect Every Item in Your Everyday World 2 You d First Ask Why? To connect people and businesses to items To identify, locate
More informationCode of Conduct. Human Resources Policies and Procedures. UCD/HRO/Conduct/048
1NHSBT Code of Conduct UCD/HRO/Conduct/048 Version Issued: February 2013v1.1 Human Resources Policies and Procedures Code of Conduct UCD/HRO/Conduct/048 1 Policy UCD/HRO/Conduct/048 Title NHSBT Code of
More informationGUIDANCE FOR INDUSTRY. Questions and Answers
GUIDANCE FOR INDUSTRY Prescription Drug Marketing Act (PDMA) Requirements Questions and Answers U.S. Department of Health and Human Services Food and Drug Administration Center for Drug Evaluation and
More informationMetso Code of Conduct
Metso Code of Conduct From the CEO Dear colleague, Metso is a big global company with more than 12,000 employees and operations in over 50 countries. It is important that we work as a team that shares
More informationA global view from the Pharmaceutical Industry Mathieu Aman F. Hoffmann-La Roche Ltd, Basel (Switzerland)
Impressions Kaiseraugst A global view from the Pharmaceutical Industry Mathieu Aman F. Hoffmann-La Roche Ltd, Basel (Switzerland) SETRM2016 Rastreabilidade de Medicamento Sao Paulo, Jun 2016 Agenda Worldwide,
More informationGENTING MALAYSIA BERHAD (58019-U) CODE OF CONDUCT AND ETHICS
GENTING MALAYSIA BERHAD (58019-U) CODE OF CONDUCT AND ETHICS All rights reserved. No part of this publication may be reproduced, stored in a retrieval system, or transmitted in any form or by any means,
More informationOnline Barometer Global Online Shopping Survey 2018 Facts, figures and fakery
Online Barometer Global Online Shopping Survey Facts, figures and fakery Introduction Taking it online The retail industry is in a constant state of change. Brands are competing against each other and
More informationAdvanced Techniques for Integrating Brand-Authenticating DNA into Point-of-Sale Packaging Materials
Advanced Techniques for Integrating Brand-Authenticating DNA into Point-of-Sale Packaging Materials Presented by: Rory A. Wolf Business Unit Manager ITW Pillar Technologies rwolf@pillartech.com Discussion
More informationPACKAGING INNOVATION & ANTI-COUNTERFEITING RESEARCH
Industrial Transformation Research Hub (ITRB) RESEARCH STREAM: PACKAGING INNOVATION & ANTI-COUNTERFEITING RESEARCH Research Stream: Packaging Innovation & Anti Counterfeiting 1. Know what is happening
More informationCombating counterfeit cosmetics trade in Sub-Saharan Africa
May 14 16, 2017 Dubai International Convention and Exhibition Centre, UAE www.beautyworldme.com Combating counterfeit cosmetics trade in Sub-Saharan Africa Combating counterfeit cosmetics trade in Sub
More informationBackground to the Falsified Medicines Directive and the Delegated Regulation. Susan Grieve, Principal Pharmacist, Department of Health 12 April 2016
Background to the Falsified Medicines Directive and the Delegated Regulation Susan Grieve, Principal Pharmacist, Department of Health 12 April 2016 Background to the Falsified Medicines Directive and the
More informationECTA European Communities Trade Mark Association 24th Annual Meeting in LONDON
ECTA European Communities Trade Mark Association 24th Annual Meeting in LONDON PAST, PRESENT AND THE FUTURE The Development of Trade Marks, Designs and Related Rights in Europe ENFORCEMENT OF IP RIGHTS:
More informationWe Love Drugs. We Use Drugs
Where s It Coming From? Counterfeits and Pharmaceutical Pedigree Bryan A. Liang, MD, PhD, JD San Diego Center for Patient Safety University of California, San Diego School of Medicine Institute of Health
More informationImproving Patient Safety and Supply Chain Efficiency with GS1 Standards in HEALTHCARE
Improving Patient Safety and Supply Chain Efficiency with GS1 Standards in HEALTHCARE 1 GS1 STANDARDS IN HEALTHCARE Together, we re making it possible to follow drugs and medical devices from the manufacturer
More informationCOUNTERFEIT MEDICINES IMPACT AND POTENTIAL SOLUTIONS
COUNTERFEIT MEDICINES IMPACT AND POTENTIAL SOLUTIONS October 2-3, 2012 The World Bank Innovative technologies to identify fake and substandard drugs in resource-limited settings: Supply chain related technologies
More informationHow to Identify, Disrupt, and Dismantle Unauthorized Product Distribution Annie Wood Client Service Manager MarkMonitor
Joshua Hopping Investigative Research Specialist MarkMonitor How to Identify, Disrupt, and Dismantle Unauthorized Product Distribution Annie Wood Client Service Manager MarkMonitor 2016 MarkMonitor Inc.
More informationGS1 Healthcare - Discussion paper on multi-market packs for pharmaceutical products
Purpose This GS1 Healthcare paper has been written to help demonstrate ways in which GS1 bar codes can be used to minimise the need for multiple bar codes to appear on product packaging while still enabling
More informationPurchasing for Safety Policy for Pharmaceuticals January Page 1 of 8 (Purchasing for Safety Policy for Pharmaceuticals)
Purchasing for Safety Policy for s January 2010 Page 1 of 8 (Purchasing for Safety Policy for s) Policy Title Purchasing for Safety Policy for s Policy Reference Number Acute10/006 Implementation Date
More informationU.S. Traceability: the Drug Supply Chain Security Act
U.S. Traceability: the Drug Supply Chain Security Act Connie Jung, RPh, PhD Associate Director for Policy & Communications (Acting) Office of Drug Security, Integrity and Recalls Office of Compliance U.S.
More informationThe Counterfeit Conundrum:
The Counterfeit Conundrum: 5 Best Practices for Mitigating Counterfeit Issues in the Electronics Industry Industry white paper highlighting proven strategies to limit the impact of counterfeiting issues
More informationSUPPLY CHAIN INTEGRITY POLICY
SUPPLY CHAIN INTEGRITY POLICY CHIEF EXECUTIVE S INTRODUCTION Businesses in the DCC Group buy and sell large volumes and a wide variety of products every year. Building long-term mutually-beneficial partnerships
More informationIntroduction Project Scope Impact of Research Value to Industry Current Results Future Direction Project Plan
Introduction Project Scope Impact of Research Value to Industry Current Results Future Direction Project Plan Evangelyn Alocilja P. Chahal, E. Almenar, B. Day, J. Wilson, D. Closs, T. Schoenherr, & C.
More informationHonorable Minister of Communications and Information Technology, Honorable Head of Public Procurement and Property Administration Agency - TBC
Remarks (as delivered) by Leslie Reed, USAID Ethiopia Mission Director African GS1 Healthcare Conference May 8, 2018 Addis Ababa, Ethiopia Honorable Minister of Health, Dr. Amir Aman Honorable Minister
More informationPolicy principles for a competitive healthcare environment
Policy principles for a competitive healthcare environment Pharmaceutical Research and Development Industry Malta Association (PRIMA) PRIMA is an affiliate of the European Federation of Pharmaceutical
More informationRealtime is to late. Smarter, Safer, Faster Espen Braathe Traceability Tiger Team Europe. Smarter planet opportunities are everywhere...
Realtime is to late Smarter, Safer, Faster Espen Braathe Traceability Tiger Team Europe Smarter planet opportunities are everywhere... safe pharmaceuticals solutions for retail supply chains food manufacturing
More informationHUG. HUG Business Case. Princeton, NJ Ed Dzwill J&J Global Pharm Sourcing Group
HUG HUG Business Case Princeton, NJ Ed Dzwill J&J Global Pharm Sourcing Group Business Case - Overview Objective: The Case for Global Standards: Creating the Business Case for Global Data Standards in
More informationAnti-Counterfeit Control Plan Version A Dated 08/24/2018
Anti-Counterfeit Control Plan Version A Dated 08/24/2018 1 P a g e 1.0 Purpose This procedure describes the Anti-Counterfeit Control Plan at Gigli Enterprises, Inc., herein referred to as GEI, in compliance
More informationRecommendations on a harmonised implementation of the EU Falsified Medicines Directive using GS1 standards
Executive Summary The EU Falsified Medicines Directive 2011/62/EU (FMD) and the supplementing Commission Delegated Regulation 2016/161 require the interoperability of product verification repositories
More informationLife Sciences Courseware. Knowledge. Performance. Impact.
Life Sciences Courseware Knowledge. Performance. Impact. Now there s a flexible, affordable way to achieve your compliance training goals. In the Life Sciences industry, it s vital that your people are
More information